Sterling Capital Management’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Other funds holding PBYI
ACA
Sterling Capital Management's PBYI Position: Q3 2026 in Review
Sterling Capital Management increased its Puma Biotechnology (PBYI) stake by 16% in Q3 2026, buying an estimated $1.19K and bringing the position to 966 shares worth $9.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2545.
Sterling Capital Management first reported a position in PBYI in Q1 2015 and has held it in 10 quarters since. The position peaked at $353K in Q1 2015. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.
- Sterling Capital Management held 966 shares of Puma Biotechnology worth $9.6K as of Q3 2026.
- Sterling Capital Management bought 135 Puma Biotechnology shares in Q3 2026, an estimated $1.19K.
- Puma Biotechnology made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2545 holding.
- Sterling Capital Management first reported a position in Puma Biotechnology in Q1 2015 and has held it in 10 quarters since.
- Sterling Capital Management's Puma Biotechnology position peaked at $353K in Q1 2015.
- 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.
Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.